Clinical Study
The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Figure 4
Changes in AD score in the rebamipide-treated group and control group. Treatment with rebamipide resulted in significant improvements in keratopathy at 8 weeks, but there were no changes at 4 weeks. However, no significant difference was observed in the control group. .